What is happening with Precision BioSciences Inc. (DTIL) Stock?

BMO Capital Markets raised the price target for the Precision BioSciences Inc. (NASDAQ:DTIL) stock to ‘an Outperform’. The rating was released on June 17, 2023, according to finviz. The research report from BTIG Research has resumed the stock to Buy, with a price target set at $16. The stock was downgraded by Goldman, who disclosed in a research note on April 03, 2020, from Buy to Neutral and set the price objective to $7. In their research brief published March 05, 2020, Stifel analysts initiated the Precision BioSciences Inc.

Previous post Using Inpixon (INPX) Stock as an income source, let’s make some money!
Next post Revolution Beauty Group (LON:REVB) Reaches New 12-Month Low at $16.60